Loading...
Successful sofosbuvir treatment with ribavirin dose reduction for chronic hepatitis C virus genotype 2 infection in a patient with ulcerative colitis: a case report
BACKGROUND: Ulcerative colitis is a lifelong, immunologically mediated disease. Direct-acting antivirals (DAAs) are now available for the treatment of chronic hepatitis C virus (HCV) infection. An interferon-free regimen appears useful, safe and effective for many patients for whom interferon-based...
Na minha lista:
| Udgivet i: | BMC Gastroenterol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4940930/ https://ncbi.nlm.nih.gov/pubmed/27401874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-016-0480-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|